Posts about:
Wearable activity monitors—those handy devices you might wear on your wrist or elsewhere on your body—are increasingly common in health research. They can offer incredible insights into our daily physical activity and even our well-being - but how accurate are they, especially for specific patient populations? This is a crucial question for cancer researchers and clinicians.
The landscape of healthcare education underwent a significant transformation in the wake of the COVID-19 pandemic, particularly when it came to students’ practice placements. These work-based training modules, where healthcare students immerse themselves in clinical duties under expert supervision, are not merely supplementary activities. They are the crucible in which theoretical knowledge acquired in university classrooms is forged into practical application and know-how, a vital bridge to becoming competent registered healthcare professionals. Completing a requisite number of hours in these placements is often a non-negotiable condition for licensure.
Imagine being able to understand the severity of someone's depression just by listening to their voice. It might sound like something out of science fiction, but new research is bringing this possibility closer to reality.
Dr. Mike Aratow, co-founder and Chief Medical Officer of Ellipsis Health, recently co-authored a groundbreaking paper published in JMIR AI titled "Digital Phenotyping for Detecting Depression Severity in a Large Payor-Provider System: Retrospective Study of Speech and Language Model Performance." This study highlights a significant leap forward in using artificial intelligence to understand mental health.
Magnetic Resonance Imaging, or MRI, is an incredibly powerful tool for doctors. It gives them super detailed images they need to figure out what's going on inside a patient's body. But for kids, especially young ones, getting an MRI can be a really stressful experience. Imagine a large, unfamiliar machine, a small space you have to lie still in, and loud noises! It's enough to make anyone anxious, let alone a child.
Imagine a hospital intensive care unit (ICU). Wires, screens, and the constant, piercing sound of alarms. But what if many of those alarms don't actually require immediate action? What if they're just noise, distracting clinicians from truly critical situations? This challenge is at the heart of groundbreaking research by Dr. Akira Poncette and his team.
Monisola Jayeoba, a PhD student in the Technology and Social Behavior Program at Northwestern University, recently published a significant paper in the Journal of Medical Internet Research. The article, titled "Low-Burden Electronic Health Record Strategies for Engaging Oncologists in Digital Health Behavior Change Interventions," delves into how oncologists prefer to be involved when their patients participate in digital health behavior change interventions.
Imagine a world where your healthcare information flows seamlessly between your doctor, specialists, and even your pharmacy. This isn't a futuristic dream, but a goal that Fast Healthcare Interoperability Resources (FHIR) aims to make a reality. FHIR provides a crucial set of standards for software companies developing health information systems, enabling these systems to "speak to each other" with unprecedented ease. The widespread adoption of FHIR promises to revolutionize healthcare by promoting data sharing, improving accessibility for patients and providers, and ultimately enhancing the quality of care.
Professor Gemma Sharp, a Clinical Psychologist based in Melbourne, Australia, and the Founding Director of the International Consortium for Research in Eating Disorders, recently led the publication of a significant paper in the Journal of Medical Internet Research. The article, titled "The Effectiveness of a Chatbot Single-Session Intervention for People on Waitlists for Eating Disorder Treatment: Randomized Controlled Trial," explores a novel approach to supporting individuals awaiting eating disorder treatment.
Botulinum toxin injections have become a cornerstone of aesthetic medicine, offering a popular solution for reducing wrinkles and achieving a more youthful appearance. However, as more patients seek these treatments, and often start at a younger age, a growing concern has emerged: botulinum toxin nonresponse.
